临床相关性精准医学研究报告指南:BePRECISE清单
精准医学研究缺乏统一报告标准。BePRECISE联盟由23名精准医学、心血管代谢病、统计学、编辑及有亲身经历专家组成,通过范围综述、改良德尔菲法和名义组法制定报告指南。清单含23个条目、分5部分,含健康公平专节,供研究者、审稿人和编辑采用以促进精准医学的公平临床转化。
要点
- BePRECISE清单含23个条目,分为5个部分,与科研论文常规章节对应。
- 清单设健康公平专节,鼓励精准医学研究纳入传统上代表性不足的个体和社区。
- 研究者、审稿人和编辑采用该清单可促进精准医学的公平临床实施。
核心结论
- BePRECISE清单为精准医学研究提供统一报告标准,有助于研究者、审稿人和编辑促进精准医学的公平临床实施。
研究设计与样本
- BePRECISE联盟由23名精准医学、心血管代谢病、统计学、编辑及有亲身经历专家组成。
- 联盟开展范围综述,并采用改良德尔菲法和名义组法制定精准医学研究报告指南。
主要发现
- BePRECISE清单包含23个条目,分为5个部分,与科学论文的典型章节对应。
- 清单设有健康公平专节,鼓励精准医学研究纳入传统上在临床研究中代表性不足和/或医疗服务不足的个体与社区。
关键数值与推荐
- BePRECISE清单共23个条目,分为5个部分。
- 清单包含1个健康公平专节。
临床怎么用
- 研究者、审稿人和编辑采用BePRECISE清单,可促进精准医学的公平临床实施。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Precision medicine should aspire to reduce error and improve accuracy in medical and health recommendations by comparison with contemporary practice, while maintaining safety and cost-effectiveness. The etiology, clinical manifestation and prognosis of diseases such as obesity, diabetes, cardiovascular disease, kidney disease and fatty liver disease are heterogeneous. Without standardized reporting, this heterogeneity, combined with the diversity of research tools used in precision medicine studies, makes comparisons across studies and implementation of the findings challenging. Specific recommendations for reporting precision medicine research do not currently exist. The BePRECISE (Better Precision-data Reporting of Evidence from Clinical Intervention Studies & Epidemiology) consortium, comprising 23 experts in precision medicine, cardiometabolic diseases, statistics, editorial and lived experience, conducted a scoping review and participated in a modified Delphi and nominal group technique process to develop guidelines for reporting precision medicine research. The BePRECISE checklist comprises 23 items organized into 5 sections that align with typical sections of a scientific publication. A specific section about health equity serves to encourage precision medicine research to be inclusive of individuals and communities that are traditionally under-represented in clinical research and/or underserved by health systems. Adoption of BePRECISE by investigators, reviewers and editors will facilitate and accelerate equitable clinical implementation of precision medicine.
引用
- Lim SS, Semnani-Azad Z, Morieri ML, et al. Reporting guidelines for precision medicine research of clinical relevance: the BePRECISE checklist. Nat Med. 2024. PMID: 39030405. doi:10.1038/s41591-024-03033-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。